Dosimetric feasibility analysis and presentation of an isotoxic dose-escalated radiation therapy concept for glioblastoma used in the PRIDE trial (NOA-28; ARO-2022-12)
Titel:
Dosimetric feasibility analysis and presentation of an isotoxic dose-escalated radiation therapy concept for glioblastoma used in the PRIDE trial (NOA-28; ARO-2022-12)
Auteur:
Bodensohn, Raphael Fleischmann, Daniel F. Maier, Sebastian H. Anagnostatou, Vasiliki Garny, Sylvia Nitschmann, Alexander Büttner, Marcel Mücke, Johannes Schönecker, Stephan Unger, Kristian Hoffmann, Elgin Paulsen, Frank Thorwarth, Daniela Holzgreve, Adrien Albert, Nathalie L. Corradini, Stefanie Tabatabai, Ghazaleh Belka, Claus Niyazi, Maximilian